The effect of time between venipuncture, processing and freezing on the measurement of coagulation factor levels

Journal of Thrombosis and Haemostasis

Volumn 10, Issue 8, 2012, Pages 1691-1693

  Engbers, M J ^a   Cushman, M ^b   Rosendaal, F R ^a   Van Hylckama, Vlieg A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; FIBRINOGEN; PROTHROMBIN;

BLOOD CULTURE; BLOOD SAMPLING; CENTRIFUGATION; CRYOPRESERVATION; FEMALE; FREEZING; HUMAN; HUMAN EXPERIMENT; LETTER; MALE; MEASUREMENT; NORMAL HUMAN; PRIORITY JOURNAL; ROOM TEMPERATURE; STUDENT T TEST; VEIN PUNCTURE; VENOUS BLOOD;

ADULT; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; BLOOD COAGULATION TESTS; CENTRIFUGATION; FEMALE; FREEZING; HUMANS; MALE; NETHERLANDS; PHLEBOTOMY; REPRODUCIBILITY OF RESULTS; SPECIMEN HANDLING; TIME FACTORS; YOUNG ADULT;

EID: 84865230575     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2012.04792.x     Document Type: Letter

References (13)

1. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurence of deep vein thrombosis. Lancet 1995; 345: 152-5.
2. Meijers JC, Tekelenburg WL, Bouma BN, Bertina RM, Rosendaal FR. High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med 2000; 342: 696-701.
3. Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Tracy RP, Aleksic N, Folsom AR. Venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). Am J Med 2002; 113: 636-42.
4. Rosendaal FR. Risk factors for venous thrombotic disease. Thromb Haemost 1999; 82: 610-19.
5. Cushman M, O'Meara ES, Folsom AR, Heckbert SR. Coagulation factors IX through XIII and the risk of future venous thrombosis: the longitudinal investigation of thromboembolism etiology. Blood 2009; 114: 2878-83.
6. Lippi G, Franchini M, Montagnana M, Salvagno GL, Poli G, Guidi GC. Quality and reliability of routine coagulation testing: can we trust that sample? Blood Coagul Fibrinolysis 2006; 17: 513-19.
7. Lewis MR, Callas PW, Jenny NS, Tracy RP. Longitudinal stability of coagulation, fibrinolysis, and inflammation factors in stored plasma samples. Thromb Haemost 2001; 86: 1495-500.
8. Favaloro EJ, Soltani S, McDonald J. Potential laboratory misdiagnosis of hemophilia and von Willebrand disorder owing to cold activation of blood samples for testing. Am J Clin Pathol 2004; 122: 686-92.
9. Böhm M, Täschner S, Kretzschmar E, Gerlach R, Favaloro EJ, Scharrer I. Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand disease. Blood Coagul Fibrinolysis 2006; 17: 39-45.
10. Seligsohn U, Østerud B, Griffina JH, Rapaport SI. Evidence for the participation of both activated factor XII and activated factor IX in cold-promoted activation of factor VII. Thromb Res 1978; 13: 1049-56.
11. Adcock DM, Hoefner DM, Kottke-Marchant KK, Marlar RA, Szamosi DI, Warunek DJ. Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays; Approved Guideline, 5th edn. Document H21-A5. Wayne, PA: CLSI, 2008.
12. Clauss A. Rapid physiological coagulation method in determination of fibrinogen. Acta Haematol 1957; 17: 237-46.
13. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-10.